Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6396 |
(R)-(-)-Gossypol acetic acid
(-)-Gossypol acetic acid,AT-101 (acetic acid),(R)-Gossypol acetic acid,AT101醋酸,AT101,AT101 acetate |
BCL; Autophagy | Apoptosis; Autophagy |
(R)-(-)-Gossypol acetic acid (AT101 acetate) 是天然产物 Gossypol 的左旋异构体,与 Bcl-2、Bcl-xL 和 Mcl-1 结合,Ki 为 0.32 μM、0.48 μM 和 0.18 μM。 | |||
TP2105L |
UFP-101 acetate
UFP-101 acetate(849024-68-6 free base) |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
UFP-101 acetate 是一种特异性和竞争性 NOP 受体拮抗剂 (pKi = 10.24),其特异性是 δ、μ 和 κ 阿片受体的 3000 倍以上。 | |||
T64692 |
AMY-101 acetate
|
||
Complement component C3 plays a particularly versatile role in this process by keeping the cascade alert, acting as a point of convergence of activation pathways, fueling the amplification of the complement response, exerting direct effector functions, and helping to coordinate downstream immune responses[3]. In C3-/- mice alcohol-induced liver steatosis is absent or strongly reduced after chronic or acute alcohol exposure. This suggests that the complement system and its component C3 contribute... |